Cargando…
European randomized study of prostate cancer screening: first-year results of the Finnish trial
Approximately 20 000 men 55–67 years of age from two areas in Finland were identified from the Population Registry and randomized either to the screening arm (1/3) or the control arm (2/3) of a prostate cancer screening trial. In the first round, the participation rate in the screening arm was 69%....
Autores principales: | Määttänen, L, Auvinen, A, Stenman, U-H, Rannikko, S, Tammela, T, Aro, J, Juusela, H, Hakama, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362232/ https://www.ncbi.nlm.nih.gov/pubmed/10098761 http://dx.doi.org/10.1038/sj.bjc.6690194 |
Ejemplares similares
-
Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial
por: Määttänen, L, et al.
Publicado: (2007) -
False-positive screening results in the Finnish prostate cancer screening trial
por: Kilpeläinen, T P, et al.
Publicado: (2010) -
Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial
por: Veitonmäki, T, et al.
Publicado: (2014) -
Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
por: Murtola, T J, et al.
Publicado: (2009) -
Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.
por: Auvinen, A., et al.
Publicado: (1996)